Tonix Pharmaceuticals Prices $9.0 Million Public Offering
November 15, 2019 at 09:36 AM EST
Tonix Pharmaceuticals Holding Corp., announced today the pricing of an underwritten public offering with expected total gross proceeds of $9.0 million before deducting underwriting discounts, commissions and other offering expenses.